Company Filing History:
Years Active: 2020-2023
Title: Yuyuan Wang: Innovator in Therapeutic Delivery Systems
Introduction
Yuyuan Wang is a prominent inventor based in Madison, WI (US), known for his significant contributions to the field of therapeutic delivery systems. With a total of 4 patents, Wang has focused on developing innovative solutions for the efficient delivery of therapeutic agents, particularly in cancer treatment.
Latest Patents
Wang's latest patents include groundbreaking work on therapeutic cationic peptides and unimolecular nanoparticles. One of his notable inventions involves peptides that have at least about 85% sequence identity to RYRPRAPIIAVT (SEQ ID NO: 1). These cationic peptides are designed to inhibit PKM2 methylation, offering potential treatment options for breast cancer and other conditions characterized by PKM2 overexpression. Additionally, he has developed a polyplex delivery system for proteins, nucleic acids, and protein/nucleic acid complexes. This system utilizes nanoplexes that comprise a payload selected from proteins and/or polynucleic acids, complexed with various copolymers to enhance delivery efficiency.
Career Highlights
Wang is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovation in therapeutic delivery systems. His work has garnered attention for its potential impact on cancer treatment and other medical applications.
Collaborations
Wang collaborates with esteemed colleagues such as Shaoqin Gong and Krishanu Saha, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yuyuan Wang's contributions to the field of therapeutic delivery systems highlight his role as a leading inventor in the medical research community. His innovative patents and collaborative efforts continue to pave the way for advancements in cancer treatment and beyond.